The circle of life by Benn, Carol-Ann
South African Medical Journal 
First published January 1884
August 2013, Vol. 103, No. 8 SAMJ
496  August 2013, Vol. 103, No. 8  SAMJ
The circle of life
 I was considering material for the privilege of writing 
this guest editorial on breast cancer in South Africa 
(SA) while strolling the streets of New York after a 
whistle-stop visit to premiere breast cancer units in 
the USA. I wandered past the advert to ‘The Lion 
King’ (proudly African) and thought about the circle of breast cancer 
management seen in the last half-century and how this has affected 
women in SA diagnosed with the disease.
Fifty years ago, women’s movements and clinicians started promoting 
certain aspects of breast health that steadily gained momentum 
throughout the world. Now it would seem that we have come full circle.
The first circle: Breast cancer screening 
This is an emotive topic that has circled from no screening at all, to 
studies showing poor value and lack of success in self breast examination 
and clinical breast examination, to worldwide acceptance of screening 
mammography in women 40 years old and older. The November 2012 
NEJM review[1] created a stir, as well as many heated debates, resulting in 
a move back to self breast examination due to a perceived lack of success 
in screening mammography in actually altering breast cancer mortality. 
Maybe in a country like ours that cannot afford effective screening, 
we can lead the way with a reasonably balanced approach, awareness 
and teaching around breast examination (particularly as 60% of 
cancers here are diagnosed at sizes over 3 cm), more use of 
ultrasound-guided core biopsy diagnosis, and selective use of digital 
mammography and magnetic resonance imaging (MRI).
SA still gets a large zero and not a circle for the lack of acceptance of 
radiological-guided core biopsies for breast cancer, and the significant 
overuse of surgical biopsy diagnoses and clinician-directed pressure into 
urgent and ‘emergency mastectomy’ followed by adjuvant treatment. 
The second circle: The move from the 
ablative mastectomies of the 1960s 
to breast conserving surgery and 
radiation therapy
The National Surgical Adjuvant Breast and Bowel Project (NSABP) 
trials by Fisher et al.,[2] showing equal survival outcomes with breast 
conserving surgery v. mastectomy, paved the way for the breast 
conservation era. Initial problems with large excisions, resulting in 
poor aesthetics, drove the migration towards pushing the aesthetics 
boundaries with the use of a variety of oncoplastic techniques – breast 
reduction reconstructions, local parenchymal flaps, larger autologous 
flaps – to the acceptance of closer margins to larger tumour size 
excision ratios and now back to the current trend, according to the 
Surveillance, Epidemiology and End Results (SEER) database of 
mastectomy (including ‘prophylactic’ risk reduction mastectomy),[3] 
only now with prosthetic reconstruction and nipple saving techniques 
(Barbie breasts at all costs!). 
A full circle: With many new questions
Why are women now electing to remove breasts – both affected and 
essentially normal breasts? Is the answer as simple as our ability 
to reconstruct equal ‘Barbie breasts’ or is it more complex? Do 
repeated mammograms and call-backs and core biopsies, or over-
diagnosing of potential pathology on MRI scans, and clinician-driven 
suggestions play a role in the type of breast cancer surgery offered?
And does the SA that now offers many good multidisciplinary units 
stand divided once again with the line firmly drawn between those 
clinicians who insist on breast conservation and those who don’t. 
Possibly the rainbow nation colours should shine and, as there 
are many different colours, so there are many different options, and 
in the proud month of August we should realise that as long as safe 
cancer rules apply, women should have some say as to how their 
feminine parts are treated.
The circle of change has rolled from surgery being the only real 
treatment of breast cancer, to the understanding of the biology of 
cancer, from the Halstedian concepts of breast cancer spread, to 
understanding the systemic nature of the disease, and the systemic 
treatment of the disease and the genetic profiling of cancers.
We have circled from the early 1970s understanding of the value of 
tamoxifen (a not-so-simple selective oestrogen receptor modulator) 
and other endocrine therapy, to the use of systemic chemotherapy 
for almost all invasive tumours over 10 mm in size. We now offer 
genetic profiling of cancers, resulting in less chemotherapy and more 
individualised treatment plans.
Possibly the biggest modern circle is the understanding of the whole 
– the concept that any break in a chain results in a suboptimal outcome.
Today, breast cancer management throughout the world, and 
in many centres in SA, has lead the way with the concept 
of multidisciplinary care, with many specialists participating 
in a combined approach to ensure better patient care. Doctors 
from radiology, pathology, oncology, surgery, and allied specialists 
(psychology, nursing) commu nicate 
and take time to ensure best patient 
care – with the circle or wheel 
being the patient who can move 
on from a devastating diagnosis – 
and drive the process to a united 
approach that ensures holistic 
patient care. Perhaps we can hold 




1. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. 
NEJM 2012;367:1998-2005. [http://dx.doi.org/10.1056/NEJMoa1206809]
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total 
mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. 
NEJM 2002;347:1233-1241. [http://dx.doi.org/10.1056/NEJMoa022152]
3. US National Cancer Institute. Surveillance, Epidemiology and End Results. http://seer.cancer.gov/ 
(accessed 5 July 2013).
4. http://www.mylionking.com/wiki/Pride_Rock (accessed 5 July 2013).




















SAMJA4PeplocJAugust2013.indd   1 7/12/13   11:34 AM
